The strategy’s experienced, well-resourced team and its consistent, quality-focused process, complemented by a flexible value sleeve, support maintaining an Above Average rating for both the People and Process Pillars.
Morgan Stanley Institutional Fund, Inc. International Equity Portfolio Class A MIQBX
- NAV / 1-Day Return 7.16 / −1.11 %
- Total Assets 283.7M
-
Adj. Expense Ratio
1.240%
- Expense Ratio 1.170%
- Distribution Fee Level Above Average
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 5.76%
- Turnover 46%
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MIQBX
Will MIQBX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MIQBX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MIQBX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 4.25 | 12M | Technology |
Deutsche Boerse AG | 4.15 | 12M | Financial Services |
L'Oreal SA | 3.65 | 10M | Consumer Defensive |
Shell PLC | 3.60 | 10M | Energy |
London Stock Exchange Group PLC | 3.57 | 10M | Financial Services |
ASML Holding NV | 3.47 | 10M | Technology |
Keyence Corp | 3.40 | 10M | Technology |
Diploma PLC | 3.04 | 9M | Industrials |
AstraZeneca PLC | 3.03 | 9M | Healthcare |
Haleon PLC | 2.84 | 8M | Healthcare |
United States